Plante Moran Financial Advisors’s Astrana Health ASTH Stock Holding History

Plante Moran Financial Advisors’s Portfolio ASTH Stock Details ASTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$278	Buy	+6	New	+$216	﹤0.01%	1338

Other funds holding ASTH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

IWS

Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Westmount Partners Los Angeles, California $457M AUM 31.05% 1-Year Est. Return

Plante Moran Financial Advisors's ASTH Position: Q2 2026 in Review

Plante Moran Financial Advisors opened a new position in Astrana Health (ASTH) in Q2 2026: 6 shares worth $278. The stake represents ﹤0.01% of the portfolio and ranks #1338 among its holdings.

81 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

Plante Moran Financial Advisors held 6 shares of Astrana Health worth $278 as of Q2 2026.
Astrana Health was a new Plante Moran Financial Advisors position in Q2 2026.
Astrana Health made up ﹤0.01% of Plante Moran Financial Advisors's portfolio in Q2 2026, its #1338 holding.
81 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Plante Moran Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.